Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Schalla

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Infection and Immunity|June 1, 1975
Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenesW O Schalla, W Johnson
Israel Journal of Medical Sciences|June 1, 1987
Western blot analysis of the human serum response to Mycoplasma hominisW O Schalla, H R Harrison
Journal of Clinical Microbiology|December 1, 1984
Evaluation of a C-reactive protein latex agglutination detection test with sera from patients with sexually transmitted diseasesW O Schalla, R J Arko, S E Thompson
MLO: Medical Laboratory Observer|November 3, 1997
Quality assessment activities in Latin America and the CaribbeanJ R Cruz, W O Schalla, S A Larsen
Infection and Immunity|March 1, 1979
Immunological and serological diversity of Neisseria gonorrhoeae: identification of new immunotypes and highly protective strainsK H Wong, R J Arko, W O Schalla, et al.
The Journal of Infectious Diseases|May 1, 1979
Complement-enhanced immunity to infection with Neisseria gonorrhoeae in miceR J Arko, K H Wong, F J Steurer, et al.
Journal of Clinical Microbiology|February 1, 1982
Simple, transparent medium for study of legionellaeS R Johnson, W O Schalla, K H Wong, et al.
Journal of Clinical Microbiology|August 1, 1990
Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testingR N Taylor, T L Hearn, W O Schalla, et al.
Journal of Clinical Microbiology|September 1, 1985
Epidemiological characterization of Neisseria gonorrhoeae by lectinsW O Schalla, W L Whittington, R J Rice, et al.
Archives of Pathology & Laboratory Medicine|March 1, 1990
Centers for Disease Control perspective on quality assurance for human immunodeficiency virus type 1 antibody testing. Model Performance Evaluation ProgramR O Valdiserri, R N Taylor, T L Hearn, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Infection and Immunity|June 1, 1975
Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenesW O Schalla, W Johnson
Israel Journal of Medical Sciences|June 1, 1987
Western blot analysis of the human serum response to Mycoplasma hominisW O Schalla, H R Harrison
Journal of Clinical Microbiology|December 1, 1984
Evaluation of a C-reactive protein latex agglutination detection test with sera from patients with sexually transmitted diseasesW O Schalla, R J Arko, S E Thompson
MLO: Medical Laboratory Observer|November 3, 1997
Quality assessment activities in Latin America and the CaribbeanJ R Cruz, W O Schalla, S A Larsen
Infection and Immunity|March 1, 1979
Immunological and serological diversity of Neisseria gonorrhoeae: identification of new immunotypes and highly protective strainsK H Wong, R J Arko, W O Schalla, et al.
The Journal of Infectious Diseases|May 1, 1979
Complement-enhanced immunity to infection with Neisseria gonorrhoeae in miceR J Arko, K H Wong, F J Steurer, et al.
Journal of Clinical Microbiology|February 1, 1982
Simple, transparent medium for study of legionellaeS R Johnson, W O Schalla, K H Wong, et al.
Journal of Clinical Microbiology|August 1, 1990
Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testingR N Taylor, T L Hearn, W O Schalla, et al.
Journal of Clinical Microbiology|September 1, 1985
Epidemiological characterization of Neisseria gonorrhoeae by lectinsW O Schalla, W L Whittington, R J Rice, et al.
Archives of Pathology & Laboratory Medicine|March 1, 1990
Centers for Disease Control perspective on quality assurance for human immunodeficiency virus type 1 antibody testing. Model Performance Evaluation ProgramR O Valdiserri, R N Taylor, T L Hearn, et al.
Pageof 4